Dermatol. praxi. 2024;18(2):108-111 | DOI: 10.36290/der.2024.020

Bimekizumab in patient with psoriasis and psoriatic spondylarthritis

MUDr. Marie Policarová
Kožní oddělení, Nemocnice Jihlava, p. o.

We present the case report of a 40year-old female patient with psoriasis ant psoriatic spondylarthritis, who was treated with whole-body phototherapy, methotrexate. Since March 2023 she is taking bimekizumab with an excellent effect on skin manifestations and a good effect on joint problems.

Keywords: psoriasis, psoriatic spondylarthritis.

Accepted: May 29, 2024; Published: June 3, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Policarová M. Bimekizumab in patient with psoriasis and psoriatic spondylarthritis. Dermatol. praxi. 2024;18(2):108-111. doi: 10.36290/der.2024.020.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Hercogová J, et. al. Klinická dermatovenerologie 1. díl. Praha: Mladá fronta, 2019; 166-167.
    2. SmPC Bimzelx. Available from: www.sukl.cz.

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.